BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25385310)

  • 1. Cost effectiveness of human papillomavirus-16/18 genotyping in cervical cancer screening.
    Huh WK; Williams E; Huang J; Bramley T; Poulios N
    Appl Health Econ Health Policy; 2015 Feb; 13(1):95-107. PubMed ID: 25385310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The budget impact of cervical cancer screening using HPV primary screening.
    Wright T; Huang J; Baker E; Garfield S; Hertz D; Cox JT
    Am J Manag Care; 2016 Mar; 22(3):e95-105. PubMed ID: 26978241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology.
    Termrungruanglert W; Khemapech N; Tantitamit T; Havanond P
    J Gynecol Oncol; 2019 Mar; 30(2):e17. PubMed ID: 30740950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.
    Demarteau N; Van Kriekinge G; Simon P
    Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of High-Risk Human Papillomavirus Testing With Messenger RNA Versus DNA Under United States Guidelines for Cervical Cancer Screening.
    Ting J; Smith JS; Myers ER
    J Low Genit Tract Dis; 2015 Oct; 19(4):333-9. PubMed ID: 26225945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
    Bidus MA; Maxwell GL; Kulasingam S; Rose GS; Elkas JC; Chernofsky M; Myers ER
    Obstet Gynecol; 2006 May; 107(5):997-1005. PubMed ID: 16648402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of primary HPV screening for cervical cancer in Germany--a decision analysis.
    Sroczynski G; Schnell-Inderst P; Mühlberger N; Lang K; Aidelsburger P; Wasem J; Mittendorf T; Engel J; Hillemanns P; Petry KU; Krämer A; Siebert U
    Eur J Cancer; 2011 Jul; 47(11):1633-46. PubMed ID: 21482103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies.
    Holmes J; Hemmett L; Garfield S
    Eur J Health Econ; 2005 Mar; 6(1):30-7. PubMed ID: 15682286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Primary HPV Screening Strategies and Triage With Cytology or Dual Stain for Cervical Cancer.
    Tantitamit T; Khemapech N; Havanond P; Termrungruanglert W
    Cancer Control; 2020; 27(1):1073274820922540. PubMed ID: 32372659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
    Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
    Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening.
    Harper DM; Anderson RJ; Baker E; Yu TM
    Cancer Prev Res (Phila); 2023 Jul; 16(7):393-404. PubMed ID: 37210751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model to evaluate the costs and clinical effectiveness of human papilloma virus screening compared with annual papanicolaou cytology in Germany.
    Petry KU; Barth C; Wasem J; Neumann A
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():132-139. PubMed ID: 28363186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triage of women with negative cytology and positive high-risk HPV: an analysis of data from the SHENCCAST II/III studies.
    Goodrich SK; Pretorius RG; Du H; Wu R; Belinson JL
    J Low Genit Tract Dis; 2014 Apr; 18(2):122-7. PubMed ID: 24270196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
    Castle PE; Reid J; Dockter J; Getman D
    J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of strategies for managing women with equivocal cytological results in Brazil.
    Vanni T; Legood R; Franco EL; Villa LL; Luz PM; Schwartsmann G
    Int J Cancer; 2011 Aug; 129(3):671-9. PubMed ID: 20886598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany.
    Sroczynski G; Schnell-Inderst P; Mühlberger N; Lang K; Aidelsburger P; Wasem J; Mittendorf T; Engel J; Hillemanns P; Petry KU; Krämer A; Siebert U
    GMS Health Technol Assess; 2010 Apr; 6():Doc05. PubMed ID: 21289878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effective management of women with minor cervical lesions: Revisiting the application of HPV DNA testing.
    Pedersen K; Burger EA; Sy S; Kristiansen IS; Kim JJ
    Gynecol Oncol; 2016 Nov; 143(2):326-333. PubMed ID: 27542966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.
    Reynales-Shigematsu LM; Rodrigues ER; Lazcano-Ponce E
    Arch Med Res; 2009 Aug; 40(6):503-13. PubMed ID: 19853192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands.
    Luttjeboer J; Setiawan D; Cao Q; Cahh Daemen T; Postma MJ
    Vaccine; 2016 Dec; 34(50):6381-6387. PubMed ID: 27816370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.